TRP Stock Overview
A clinical stage biopharmaceutical company, develops advanced wound healing products for chronic wounds and the aftercare of cosmetic procedures in Australia. More details
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Tissue Repair Ltd Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | AU$0.26 |
52 Week High | AU$0.50 |
52 Week Low | AU$0.18 |
Beta | 0.48 |
11 Month Change | -25.71% |
3 Month Change | -33.33% |
1 Year Change | 10.64% |
33 Year Change | -53.57% |
5 Year Change | n/a |
Change since IPO | -62.59% |
Recent News & Updates
Recent updates
Shareholder Returns
TRP | AU Biotechs | AU Market | |
---|---|---|---|
7D | 2.0% | -3.6% | 1.5% |
1Y | 10.6% | 10.0% | 17.2% |
Return vs Industry: TRP matched the Australian Biotechs industry which returned 10% over the past year.
Return vs Market: TRP underperformed the Australian Market which returned 17.2% over the past year.
Price Volatility
TRP volatility | |
---|---|
TRP Average Weekly Movement | 9.5% |
Biotechs Industry Average Movement | 9.7% |
Market Average Movement | 8.6% |
10% most volatile stocks in AU Market | 17.3% |
10% least volatile stocks in AU Market | 3.4% |
Stable Share Price: TRP has not had significant price volatility in the past 3 months compared to the Australian market.
Volatility Over Time: TRP's weekly volatility has decreased from 18% to 10% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2012 | n/a | Tony Charara | tissuerepair.com.au |
Tissue Repair Ltd, a clinical stage biopharmaceutical company, develops advanced wound healing products for chronic wounds and the aftercare of cosmetic procedures in Australia. It is developing TR-987, including Glucoprime technology for the treatment of chronic wounds, burns, and other complex wounds; and TR Pro+ for aftercare of minimally invasive cosmetic procedures. The company was incorporated in 2012 and is based in Sydney, Australia.
Tissue Repair Ltd Fundamentals Summary
TRP fundamental statistics | |
---|---|
Market cap | AU$16.02m |
Earnings (TTM) | -AU$4.14m |
Revenue (TTM) | AU$1.79m |
8.8x
P/S Ratio-3.8x
P/E RatioIs TRP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
TRP income statement (TTM) | |
---|---|
Revenue | AU$1.79m |
Cost of Revenue | AU$0 |
Gross Profit | AU$1.79m |
Other Expenses | AU$5.93m |
Earnings | -AU$4.14m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.068 |
Gross Margin | 100.00% |
Net Profit Margin | -231.07% |
Debt/Equity Ratio | 0% |
How did TRP perform over the long term?
See historical performance and comparison